The $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found.
Sigma-Aldrich Corp. went toe-to-toe against larger rival Thermo Fisher Scientific Inc. to acquire Life Technologies Corp., said people with knowledge of the matter, bidding through the weekend before falling short against Thermo’s $13.6 billion offer.
John Paulson, the billionaire hedge- fund manager battered by the selloff in gold, pared stakes in gold miners last quarter while adding shares of companies that stand to benefit from a stronger economy.
Thermo Fisher Scientific Inc., the second-biggest maker of life-sciences equipment by market value, agreed to buy Life Technologies Corp. for $13.6 billion in cash in a deal that expands its reach in medical testing.
Thermo Fisher Scientific Inc. is the leading bidder for Life Technologies Corp., having won exclusive negotiating rights over the weekend with a bid for more than $75 a share, said two people familiar with the matter.